True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature-Reference-Cited by-同舟云学术

True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature

Published:2021-06 Issue: Volume:507 Page:89-96
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Nicolazzo Chiara^ORCID,Barault Ludovic^ORCID,Caponnetto Salvatore,De Renzi Gianluigi,Belardinilli Francesca,Bottillo Irene^ORCID,Bargiacchi Simone^ORCID,Macagno Marco^ORCID,Grammatico Paola,Giannini Giuseppe,Cortesi Enrico^ORCID,Di Nicolantonio Federica^ORCID,Gazzaniga Paola

Funder

Fondazione Pezcoller

Sapienza Università di Roma

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference32 articles.

1. How we treat metastatic colorectal cancer;De Falco;ESMO Open,2020

2. Mechanisms of innate and acquired resistance to anti-EGFR therapy: a review of current knowledge with a focus on rechallenge therapies;Parseghian;Clin. Canc. Res.,2019

3. Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer;Misale;Nature,2012

4. Liquid biopsy as a tool exploring in real-time both genomic perturbation and resistance to EGFR antagonists in colorectal cancer;Internò;Front. Oncol.,2020

5. Emerging RAS, BRAF, and EGFR mutations in cell-free DNA of metastatic colorectal patients are associated with both primary and secondary resistance to first-line anti-EGFR therapy;Yamada;Int. J. Clin. Oncol.,2020

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical features associated with NeoRAS wild-type metastatic colorectal cancer A SCRUM-Japan GOZILA substudy;Nature Communications;2024-07-13

2. Liquid biopsy for human cancer: cancer screening, monitoring, and treatment;MedComm;2024-05-28

3. Temporal dynamics of RAS mutations in circulating tumor DNA in metastatic colorectal cancer: clinical significance of mutation loss during treatment;Journal of Cancer Research and Clinical Oncology;2024-05-28

4. Circulating tumour DNA analysis and new uses of anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer;Medical alphabet;2024-05-10

5. Liquid biopsy techniques and lung cancer: diagnosis, monitoring and evaluation;Journal of Experimental & Clinical Cancer Research;2024-04-01